It can be seen from Figure 5 that propofol can reduce the expression of PCNA, CD34, and PATK protein in patients, thereby increasing the activity and content of transforming growth factor TGF-β1 by 12% and 20%, thereby inhibiting the proliferation of liver cancer cells through the Smad2 signaling pathway. This evidence concerns the gene TGFB1 and liver cancer.